Lightbridge GAAP EPS of -$0.23
Tickers: $LTBR
Read the full article at Seeking Alpha
Part of the story Jazz Pharmaceuticals Reports $755 Million IPR&D Charge Following Actio Biosciences Acquisition (3 articles)
More World news
- CorMedix Announces Acquisition of Heron Therapeutics Assets to Drive Revenue Growth
- Tetra Tech Forecasts FY 2027 Revenue Between $4.425B and $4.625B Amid Backlog Growth
- Donald Trump Jr. Steps Down from Kalshi Advisory Role Due to Conflict of Interest
- Centalion Americas Refinances and Upsizes Credit Facility to $3.5 Billion
- Nvidia Faces Leadership Transition as Jensen Huang Resigns Amid Investigation
- SOLV Energy Reports Record Q3 2026 Results and Raises Full-Year Guidance
- Clear Secure Reports Strong Q3 Earnings and Raises Full Year Guidance Amid Expansion into Identity Verification
- Nectar Launches AI Agent to Automate Influencer Discovery and Outreach
- Cohen & Company Appoints Daniel Cohen as CEO with $500 Million Revenue Target
- X-Energy Receives Early NRC Construction Permit and Anticipates Dow Investment Decision by 2027